BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.69B |
| 2 |
Apple
AAPL
|
+$892M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
+$799M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$793M |
| 5 |
GE Aerospace
GE
|
+$748M |
Top Sells
| 1 |
Tesla
TSLA
|
+$362M |
| 2 |
Utilities Select Sector SPDR Fund
XLU
|
+$345M |
| 3 |
NVIDIA
NVDA
|
+$258M |
| 4 |
MetLife
MET
|
+$257M |
| 5 |
Meta Platforms (Facebook)
META
|
+$223M |
Sector Composition
| 1 | Technology | 26.74% |
| 2 | Consumer Discretionary | 11.23% |
| 3 | Financials | 10.63% |
| 4 | Healthcare | 8.41% |
| 5 | Communication Services | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Citizens Financial Services
CZFS
$312M
| $34.5K | ﹤0.01% |
+550
| New | +$34.5K |
|
3552
Bridgewater Bancshares
BWB
$454M
| $34.4K | ﹤0.01% |
2,549
-1,875
| -42% | -$25.3K |
|
3553
NACCO Industries
NC
$297M
| $34.3K | ﹤0.01% |
1,151
+192
| +20% | +$5.73K |
|
|
SRTA
3554
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$354M
| $34.2K | ﹤0.01% |
+8,052
| New | +$34.2K |
|
3555
Voyager Therapeutics
VYGR
$233M
| $34.2K | ﹤0.01% |
6,025
-43,210
| -88% | -$245K |
|
3556
StealthGas
GASS
$272M
| $34.2K | ﹤0.01% |
6,046
-4,827
| -44% | -$27.3K |
|
3557
Solid Power
SLDP
$687M
| $34.1K | ﹤0.01% |
+18,037
| New | +$34.1K |
|
3558
Sana Biotechnology
SANA
$831M
| $33.8K | ﹤0.01% |
+20,741
| New | +$33.8K |
|
|
ESSA
3559
DELISTED
ESSA Bancorp
ESSA
| $33.7K | ﹤0.01% |
1,727
-706
| -29% | -$13.8K |
|
3560
ASP Isotopes
ASPI
$796M
| $33.7K | ﹤0.01% |
+7,429
| New | +$33.7K |
|
3561
Priority Technology Holdings
PRTH
$607M
| $33.6K | ﹤0.01% |
2,859
-13,124
| -82% | -$154K |
|
3562
Eve Holding
EVEX
$1.17B
| $33.6K | ﹤0.01% |
+6,174
| New | +$33.6K |
|
|
PLL
3563
DELISTED
Piedmont Lithium
PLL
| $33K | ﹤0.01% |
+3,776
| New | +$33K |
|
3564
iHeartMedia
IHRT
$378M
| $33K | ﹤0.01% |
+16,662
| New | +$33K |
|
3565
Microvision
MVIS
$337M
| $32.7K | ﹤0.01% |
24,949
-38,803
| -61% | -$50.8K |
|
3566
Clarus
CLAR
$146M
| $32.5K | ﹤0.01% |
7,203
-1,404
| -16% | -$6.33K |
|
3567
Vanguard Utilities ETF
VPU
$7.37B
| $32.4K | ﹤0.01% |
198
-5,639
| -97% | -$922K |
|
3568
CervoMed
CRVO
$78M
| $32.2K | ﹤0.01% |
+13,773
| New | +$32.2K |
|
|
ONL
3569
Orion Office REIT
ONL
$166M
| $32.2K | ﹤0.01% |
+8,682
| New | +$32.2K |
|
|
BCAX
3570
Bicara Therapeutics Inc. Common Stock
BCAX
$638M
| $31.9K | ﹤0.01% |
+1,830
| New | +$31.9K |
|
3571
Bel Fuse Class A
BELFA
$1.51B
| $31.8K | ﹤0.01% |
353
-1,720
| -83% | -$155K |
|
3572
Aldeyra Therapeutics
ALDX
$328M
| $31.7K | ﹤0.01% |
6,355
-7,874
| -55% | -$39.3K |
|
3573
Lightwave Logic
LWLG
$388M
| $31.7K | ﹤0.01% |
+15,091
| New | +$31.7K |
|
3574
Trevi Therapeutics
TRVI
$1.01B
| $31.7K | ﹤0.01% |
7,686
-4,244
| -36% | -$17.5K |
|
3575
Neurogene
NGNE
$281M
| $31.5K | ﹤0.01% |
1,380
-790
| -36% | -$18.1K |
|